Patients with COPD with higher levels of anxiety are more physically active

Chest

Volumn 144, Issue 1, 2013, Pages 145-151

  Nguyen, Huong Q ^a   Fan, Vincent S ^b   Herting, Jerald ^b   Lee, Jungeun ^b   Fu, Musetta ^b   Chen, Zijing ^b   Borson, Soo ^b   Kohen, Ruth ^b   Matute Bello, Gustavo ^b   Pagalilauan, Genevieve ^b   Adams, Sandra G ^c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETRY; ADULT; AGED; ANXIETY DISORDER; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COPING BEHAVIOR; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSPNEA; EXERCISE TEST; FEMALE; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERSONAL MONITOR; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUESTIONNAIRE; RESTLESSNESS; SHORTNESS OF BREATH QUESTIONNAIRE; WALKING;

EID: 84880067885     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1873     Document Type: Article

References (43)

1. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM; Estudi del Factors de Risc d'Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003; 58 (2): 100-105.
2. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006; 61 (9): 772-778.
3. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med. 2007; 175 (5): 458-463.
4. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011; 140 (2): 331-342.
5. Leidy NK. Functional status and the forward progress of merry-go-rounds: toward a coherent analytical framework. Nurs Res. 1994; 43 (4): 196-202.
6. Yohannes A, Baldwin R, Connolly M. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol. 2000; 10 (2): 193-202.
7. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest. 2010; 137 (2): 341-347.
8. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003; 65 (6): 963-970.
9. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005; 127 (4): 1205-1211.
10. Wall MP. Predictors of functional performance in communitydwelling people with COPD. J Nurs Scholarsh. 2007; 39 (3): 222-228.
11. Weaver TE, Narsavage GL. Physiological and psychological variables related to functional status in chronic obstructive pulmonary disease. Nurs Res. 1992; 41 (5): 286-291.
12. Yeh ML, Chen HH, Liao YC, Liao WY. Testing the functional status model in patients with chronic obstructive pulmonary disease. J Adv Nurs. 2004; 48 (4): 342-350.
13. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007; 167( 1): 60-67.
14. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000; 41 (6): 465-471.
15. Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005; 86 (9): 1788-1792.
16. Godoy RF, Teixeira PJ, Becker Júnior B, Michelli M, Godoy DV. Long-term repercussions of a pulmonary rehabilitation program on the indices of anxiety, depression, quality of life and physical performance in patients with COPD. J Bras Pneumol. 2009; 35 (2): 129-136.
17. Weaver TE, Richmond TS, Narsavage GL. An explanatory model of functional status in chronic obstructive pulmonary disease. Nurs Res. 1997; 46 (1): 26-31.
18. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008; 177 (7): 743-751.
19. Carrieri VK, Janson-Bjerklie S, Jacobs S. The sensation of dyspnea: a review. Heart Lung. 1984; 13 (4): 436-447.
20. Carrieri-Kohlman V, Stulbarg MS. Dyspnea: assessment and management. In: Hodgkin JE, Celli BR, Connors GL, eds. Pulmonary Rehabilitation. 3rd ed. New York: Lippincott Williams & Wilkins; 2000.
21. Giardino ND, Curtis JL, Andrei AC, et al; NETT Research Group. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a crosssectional study. Respir Res. 2010; 11: 29.
22. Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010; 65 (3): 229-234.
23. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008; 178 (9): 913-920.
24. de Voogd JN, Sanderman R, Postema K, van Sonderen E, Wempe JB. Relationship between anxiety and dyspnea on exertion in patients with chronic obstructive pulmonary disease. Anxiety Stress Coping. 2011; 24 (4): 439-449.
25. Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest. 2011; 140 (3): 618-625.
26. von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011; 140 (3): 730-736.
27. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186 (2): 155-161.
28. National Institutes of Health Clinical Center. Depression and Functional Outcomes in COPD: Impact of Genetics and Inflammation. NCT01074515. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT01074515. Updated October 15, 2012.
29. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152 (3): 1107-1136.
30. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166 (1): 111-117.
31. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998; 113 (3): 619-624.
32. Nguyen HQ, Burr RL, Gill DP, Coleman K. Validation of the Stepwatch device for measurement of free-living ambulatory activity in patients with chronic obstructive pulmonary disease. J Nurs Meas. 2011; 19 (2): 76-90.
33. Feito Y, Bassett DR, Thompson DL. Evaluation of activity monitors in controlled and free-living environments. Med Sci Sports Exerc. 2012; 44 (4): 733-741.
34. Tyo BM, Fitzhugh EC, Bassett DR Jr, John D, Feito Y, Thompson DL. Effects of body mass index and step rate on pedometer error in a free-living environment. Med Sci Sports Exerc. 2011; 43 (2): 350-356.
35. Cindy Ng LW, Jenkins S, Hill K. Accuracy and responsiveness of the stepwatch activity monitor and ActivPAL in patients with COPD when walking with and without a rollator. Disabil Rehabil. 2012; 34 (15): 1317-1322.
36. Sewell L, Singh SJ, Williams JE, Morgan MD. Seasonal variations affect physical activity and pulmonary rehabilitation outcomes. J Cardiopulm Rehabil Prev. 2010; 30 (5): 329-333.
37. Moy ML, Danilack VA, Weston NA, Garshick E. Daily step counts in a US cohort with COPD. Respir Med. 2012; 106 (7): 962-969.
38. von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007; 101 (3): 411-422.
39. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2005; 2 (4): 183-191.
40. Vinot N, Jouin M, Lhomme-Duchadeuil A, et al. Omega-3 fatty acids from fish oil lower anxiety, improve cognitive functions and reduce spontaneous locomotor activity in a nonhuman primate. PLoS ONE. 2011; 6 (6): e20491.
41. Sakamoto N, Yoshiuchi K, Kikuchi H, et al. Panic disorder and locomotor activity. Biopsychosoc Med. 2008; 2: 23.
42. Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med. 2011; 41 (2): 207-215.
43. Casaburi R, Porszasz J, Hecht A, et al; COPD Clinical Research Network. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012; 9 (1): 3-11.